Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New Weapon Against Cholera

New Weapon Against Cholera News & Analysis News From the Food and Drug Administration New Weapon Against Cholera weight or keep pounds off through nonsur- compared with a 3.5% weight loss for those Travelers to cholera-affected parts of the gical weight loss methods. The device is not who didn’t receive the device. world have a new defense against the bac- intended for people with eating disorders or Commonadverseeventsincludedbleed- terial infection. Vaxchora recently became for short-duration use by people who are ing, irritation, and infection at the tubing im- the only FDA-approved vaccine for prevent- moderately overweight (http://1.usa.gov plant site as well as pain, nausea and vom- ing cholera caused by serogroup O1 Vibrio /28Txm1s). iting, and changes in bowel habits. cholerae (http://1.usa.gov/1XeF73f). During an outpatient procedure with Although cholera is rare in the United twilight sedation, a tube is implanted into FDA Tackles Cyber Drug Crime States, a recent study reported that chol- the stomach and connected to a port that Workingwithinternationalregulatoryandlaw era is endemic in an estimated 69 coun- lies outside the body, flush against the skin enforcementauthorities,theFDAparticipated tries, more than half of which are in sub- over the abdomen. About 20 to 30 min- in an early June crackdown on websites http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

New Weapon Against Cholera

JAMA , Volume 316 (5) – Aug 2, 2016

New Weapon Against Cholera

Abstract

News & Analysis News From the Food and Drug Administration New Weapon Against Cholera weight or keep pounds off through nonsur- compared with a 3.5% weight loss for those Travelers to cholera-affected parts of the gical weight loss methods. The device is not who didn’t receive the device. world have a new defense against the bac- intended for people with eating disorders or Commonadverseeventsincludedbleed- terial infection. Vaxchora recently became for short-duration use by people...
Loading next page...
 
/lp/american-medical-association/new-weapon-against-cholera-n0hGWq0zys

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2016.9769
Publisher site
See Article on Publisher Site

Abstract

News & Analysis News From the Food and Drug Administration New Weapon Against Cholera weight or keep pounds off through nonsur- compared with a 3.5% weight loss for those Travelers to cholera-affected parts of the gical weight loss methods. The device is not who didn’t receive the device. world have a new defense against the bac- intended for people with eating disorders or Commonadverseeventsincludedbleed- terial infection. Vaxchora recently became for short-duration use by people who are ing, irritation, and infection at the tubing im- the only FDA-approved vaccine for prevent- moderately overweight (http://1.usa.gov plant site as well as pain, nausea and vom- ing cholera caused by serogroup O1 Vibrio /28Txm1s). iting, and changes in bowel habits. cholerae (http://1.usa.gov/1XeF73f). During an outpatient procedure with Although cholera is rare in the United twilight sedation, a tube is implanted into FDA Tackles Cyber Drug Crime States, a recent study reported that chol- the stomach and connected to a port that Workingwithinternationalregulatoryandlaw era is endemic in an estimated 69 coun- lies outside the body, flush against the skin enforcementauthorities,theFDAparticipated tries, more than half of which are in sub- over the abdomen. About 20 to 30 min- in an early June crackdown on websites

Journal

JAMAAmerican Medical Association

Published: Aug 2, 2016

There are no references for this article.